- Home
- AUPH vs KARO Comparison
AUPH vs KARO Comparison
Compare AUPH & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- KARO
- Stock Information
- Founded
- AUPH 1993
- KARO 2001
- Country
- AUPH Canada
- KARO Singapore
- Employees
- AUPH N/A
- KARO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- KARO Computer Software: Prepackaged Software
- Sector
- AUPH Health Care
- KARO Technology
- Exchange
- AUPH Nasdaq
- KARO Nasdaq
- Market Cap
- AUPH 1.4B
- KARO 1.4B
- IPO Year
- AUPH 1999
- KARO 2021
- Fundamental
- Price
- AUPH $12.22
- KARO $47.78
- Analyst Decision
- AUPH Strong Buy
- KARO Strong Buy
- Analyst Count
- AUPH 4
- KARO 3
- Target Price
- AUPH $12.25
- KARO $57.67
- AVG Volume (30 Days)
- AUPH 2.8M
- KARO 64.5K
- Earning Date
- AUPH 07-31-2025
- KARO 10-13-2025
- Dividend Yield
- AUPH N/A
- KARO 2.61%
- EPS Growth
- AUPH N/A
- KARO 20.28
- EPS
- AUPH 0.42
- KARO 1.73
- Revenue
- AUPH $260,111,000.00
- KARO $264,205,688.00
- Revenue This Year
- AUPH $12.15
- KARO $20.90
- Revenue Next Year
- AUPH $18.34
- KARO $16.26
- P/E Ratio
- AUPH $29.06
- KARO $27.66
- Revenue Growth
- AUPH 25.59
- KARO 11.00
- 52 Week Low
- AUPH $6.23
- KARO $34.00
- 52 Week High
- AUPH $12.53
- KARO $63.36
- Technical
- Relative Strength Index (RSI)
- AUPH 78.39
- KARO 50.78
- Support Level
- AUPH $11.18
- KARO $46.41
- Resistance Level
- AUPH $11.69
- KARO $48.65
- Average True Range (ATR)
- AUPH 0.60
- KARO 1.31
- MACD
- AUPH 0.12
- KARO 0.27
- Stochastic Oscillator
- AUPH 91.61
- KARO 79.94
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About KARO Karooooo Ltd.
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.